Outcomes of Treatment-Resistant Neovascular Age-Related Macular Degeneration Switched from Aflibercept to Faricimab

Autor: Raimondi, Raffaele, Falfeli, Tina, Bogdanova-Bennet, Anna, Varma, Deepali, Habib, Maged, Kotagiri, Ajay, Steel, David H., Grinton, Michael
Zdroj: Ophthalmology Retina; June 2024, Vol. 8 Issue: 6 p537-544, 8p
Abstrakt: Although previous studies have demonstrated the efficacy of faricimab in treatment-naive patients with neovascular age-related macular degeneration (nAMD), its outcomes in patients switched from aflibercept are less understood. This study aimed to assess clinical anatomical and functional outcomes of switching to faricimab in patients undergoing aflibercept intravitreal injections (IVIs) for nAMD with suboptimal response.
Databáze: Supplemental Index